News | October 02, 2006

GE’s FASTLab Provides Turn-Key PET Tracers

GE Healthcare announced at the Annual Congress of the European Association of Nuclear Medicine in Athens, Greece, the release of FASTlab for PET radiopharmaceutical production, a part of GE’s strategy to develop new lines of radiopharmaceuticals, including diagnostic imaging agents.
FASTLab, a new, high-performance chemistry system, features a single-use cassette system which contains pre-measured quantities of all chemicals needed for the synthesis of radiopharmaceuticals accounting for its high yield and high reproducibility. Designed to deliver turn-key production of PET tracers, the first application launched on the platform is FDG for PET.
"The clinical utility of promising new PET tracers developed by academic and commercial research labs needs to be established through multi-institutional trials before they can be approved for common radiology practice", said Dr. Juri Gelovani, Professor of Radiology and Neurology at the University of Texas, MD Anderson Cancer Center. “For such multi-institutional trials, a strictly controlled and consistent cGMP-compliant production at each site or a centralized production and distribution of novel PET tracer candidates will be essential. FASTlab is an integrated cassette-based synthesis system, which will help to accelerate the set up and execution of these trials by providing a common platform for production of PET tracers under the same standard operating procedures (SOP). The goal is to make these innovative tracers available to patients and doctors as soon as possible and at the highest attainable quality.”

Related Content

Study Demonstrates First Human Application of Novel PET Tracer for Prostate Cancer

Transaxial 11Csarcosine hybrid PET/CT showed a (triangulated) adenocarcinoma in the transition zone of the anterior right prostate gland on PET (A), CT (B), and a separately obtained T2?weighted MR sequence (C) with resulting PET/MRI registration (D). Image courtesy of M. Piert et al., University of Michigan, Ann Arbor, Mich.

News | Radiopharmaceuticals and Tracers | August 16, 2017
In the featured translational article in the August issue of The Journal of Nuclear Medicine, researchers at the...
Novel PET Tracer Detects Small Blood Clots

PET images (MIP 0-60 min) of three Cynomolgus monkeys. Strong signals are detected at the sites where inserted catheters had roughened surfaces. Almost no other background signal is visible. Only accumulation in the gallbladder becomes visible at the bottom of the image. Credit: Piramal Imaging GmbH, Berlin Germany.

News | PET Imaging | July 07, 2017
July 7, 2017 — Blood clots in veins a

While subject No. 1 (left) was judged as positive for both the neuronal injury and the amyloid load biomarker, both Alzheimer's disease biomarkers were negative in subject No. 2 (right). Image courtesy of Henryk Barthel et al., University Hospital Leipzig, Leipzig, Germany

News | PET Imaging | June 14, 2017
More people die of Alzheimer's disease than prostate and breast cancer combined. Identifying the disease before major...
News | Clinical Study | June 09, 2017
The milestone Imaging Dementia — Evidence for Amyloid Scanning (IDEAS) Study is working with government and academic...
Lantheus and GE Healthcare Sign Agreement for Worldwide Development, Commercialization of Flurpiridaz F-18
News | Radiopharmaceuticals and Tracers | May 22, 2017
May 22, 2017 — Lantheus Holdings Inc., parent company of Lantheus Medical Imaging Inc., and GE Healthcare announced t
low-dose lung CT scan

An example of a low-dose CT scan of the lungs, showing lung cancer. Image courtesy of Toshiba.

Feature | Lung Cancer | May 05, 2017 | Alison Grimes
The term mesothelioma was coined in 1909, just a few years after the introduction of medical X-ray imaging.
Australian Team Finds New Method for Producing PET Radiotracers in Higher Radiochemical Yields
News | Radiopharmaceuticals and Tracers | April 28, 2017
April 28, 2017 — Researchers at the Australian Nuclear Science and Technology Organisation (ANSTO) have led the devel
Sponsored Content | Videos | Nuclear Imaging | April 28, 2017
David Wolinsky, M.D., director of nuclear cardiology at Cleveland Clinic Florida and past-president of the American S
News | Prostate Cancer | April 24, 2017
April 24, 2017 — Cancer Targeted Technology recently announced it is focusing on small molecules that target pivotal
PET
Feature | Imaging | April 11, 2017 | By Greg Freiherr
Positron emission tomography (PET) and other brain assessments
Overlay Init